A pilot study of plasma interleukin-6 and interleukin-27 in differential diagnosis of acute respiratory distress syndrome and neonatal respiratory distress syndrome in preterm infants

LIU Chan; HE Yu; AI Qing; SHI Yuan

doi:10.7499/j.issn.1008-8830.2111184

PDF(568 KB)

Chinese Journal of Contemporary Pediatrics ›› 2022, Vol. 24 ›› Issue (4) : 428-432. DOI: 10.7499/j.issn.1008-8830.2111184

CLINICAL RESEARCH

A pilot study of plasma interleukin-6 and interleukin-27 in differential diagnosis of acute respiratory distress syndrome and neonatal respiratory distress syndrome in preterm infants

LIU Chan, HE Yu, AI Qing, SHI Yuan

Author information +

History +

Abstract

Objective To study the significance of interleukin-6 (IL-6) and interleukin-27 (IL-27) in the differential diagnosis of acute respiratory distress syndrome (ARDS) and neonatal respiratory distress syndrome (NRDS) in preterm infants. Methods The preterm infants with the manifestation of respiratory distress who were treated in the Neonatal Diagnosis and Treatment Center, Children's Hospital of Chongqing Medical University, from March to November 2021, were enrolled in this prospective study. According to the diagnosis results, they were divided into two groups: ARDS group (n=18) and NRDS group (n=20). ELISA was used to measure the plasma levels of IL-6 and IL-27. The receiver operating characteristic (ROC) curve was used to analyze the value of each index in the diagnosis of ARDS. Results The ARDS group had significantly higher plasma levels of IL-6 and IL-27 than the NRDS group (P<0.05). The ROC curve analysis showed that IL-6 had an area under the ROC curve (AUC) of 0.867 for the diagnosis of ARDS, with a sensitivity of 61.1% and a specificity of 95.0% at the cut-off value of 56.21 pg/mL. The ROC curve analysis also showed that IL-27 had an AUC of 0.881 for the diagnosis of ARDS, with a sensitivity of 83.3% and a specificity of 80.0% at the cut-off value of 135.8 pg/mL. Conclusions Plasma IL-6 and IL-27 can be used as biological indicators for early differential diagnosis of ARDS and NRDS in preterm infants.

Key words

Respiratory distress syndrome / Interleukin-6 / Interleukin-27 / Preterm infant

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

LIU Chan, HE Yu, AI Qing, SHI Yuan. A pilot study of plasma interleukin-6 and interleukin-27 in differential diagnosis of acute respiratory distress syndrome and neonatal respiratory distress syndrome in preterm infants[J]. Chinese Journal of Contemporary Pediatrics. 2022, 24(4): 428-432 https://doi.org/10.7499/j.issn.1008-8830.2111184

References

1 Wang J, Liu X, Zhu T, et al. Analysis of neonatal respiratory distress syndrome among different gestational segments[J]. Int J Clin Exp Med, 2015, 8(9): 16273-16279. PMID: 26629144. PMCID: PMC4659032.
2 Koo KY, Kim JE, Lee SM, et al. Effect of severe neonatal morbidities on long term outcome in extremely low birthweight infants[J]. Korean J Pediatr, 2010, 53(6): 694-700. PMID: 21189940. PMCID: PMC2994138. DOI: 10.3345/kjp.2010.53.6.694.
3 Qaril SA, Alsufyani AA, Muathin SH, et al. Prevalence of respiratory distress syndrome in neonates[J]. Egypt J Hosp Med, 2018, 70(2): 257-264. DOI: 10.12816/0043086.
4 De Luca D, van Kaam AH, Tingay DG, et al. The Montreux definition of neonatal ARDS: biological and clinical background behind the description of a new entity[J]. Lancet Respir Med, 2017, 5(8): 657-666. PMID: 28687343. DOI: 10.1016/S2213-2600(17)30214-X.
5 郭静雨, 陈龙, 史源. 2017年新生儿急性呼吸窘迫综合征蒙特勒诊断标准解读[J]. 中华儿科杂志, 2018, 56(8): 571-574. PMID: 30078236. DOI: 10.3760/cma.j.issn.0578-1310.2018.08.003.
6 封志纯, 赵喆, 史源. 读懂新生儿急性呼吸窘迫综合征的关键词: 叠加[J]. 中华围产医学杂志, 2021, 24(4): 273-277. DOI: 10.3760/cma.j.cn113903-20201012-01023.
7 赵凤霞, 刘光辉, 张健. IL-6和IL-8在诊断新生儿败血症中的价值研究[J]. 中国当代儿科杂志, 2015, 17(12): 1311-1315. PMID: 26695671. DOI: 10.7499/j.issn.1008-8830.2015.12.011.
8 He Y, Du WX, Jiang HY, et al. Multiplex cytokine profiling identifies interleukin-27 as a novel biomarker for neonatal early onset sepsis[J]. Shock, 2017, 47(2): 140-147. PMID: 27648693. DOI: 10.1097/SHK.0000000000000753.
9 中国医师协会新生儿科医师分会. "新生儿急性呼吸窘迫综合征"蒙特勒标准(2017年版)[J]. 中华实用儿科临床杂志, 2017, 32(19): 1456-1458. DOI: 10.3760/cma.j.issn.2095-428X.2017.19.004.
10 Mihara M, Hashizume M, Yoshida H, et al. IL-6/IL-6 receptor system and its role in physiological and pathological conditions[J]. Clin Sci (Lond), 2012, 122(4): 143-159. PMID: 22029668. DOI: 10.1042/CS20110340.
11 Voiriot G, Razazi K, Amsellem V, et al. Interleukin-6 displays lung anti-inflammatory properties and exerts protective hemodynamic effects in a double-hit murine acute lung injury[J]. Respir Res, 2017, 18(1): 64. PMID: 28424078. PMCID: PMC5397701. DOI: 10.1186/s12931-017-0553-6.
12 Tsantes A, Tsangaris I, Kopterides P, et al. The role of procalcitonin and IL-6 in discriminating between septic and non-septic causes of ALI/ARDS: a prospective observational study[J]. Clin Chem Lab Med, 2013, 51(7): 1535-1542. PMID: 23314554. DOI: 10.1515/cclm-2012-0562.
13 古裕鸟, 霍开明, 庄秀娟, 等. 新生儿急性呼吸窘迫综合征血清微小核糖核酸-181a的表达及与炎性因子的相关性[J]. 中国医刊, 2020, 55(8): 908-911. DOI: 10.3969/j.issn.1008-1070.2020.08.028.
14 宋婷阁, 张鹏举, 耿彪, 等. 新生儿急性呼吸窘迫综合征患者血清miR-183-5p的表达及与IL-1β, IL-6和TNF-α水平的相关性[J]. 现代检验医学杂志, 2021, 36(5): 55-57. DOI: 10.3969/j.issn.1671-7414.2021.05.012.
15 Pflanz S, Hibbert L, Mattson J, et al. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27[J]. J Immunol, 2004, 172(4): 2225-2231. PMID: 14764690. DOI: 10.4049/jimmunol.172.4.2225.
16 Xu F, Liu Q, Lin S, et al. IL-27 is elevated in acute lung injury and mediates inflammation[J]. J Clin Immunol, 2013, 33(7): 1257-1268. PMID: 23842867. PMCID: PMC7102048. DOI: 10.1007/s10875-013-9923-0.
17 Wirtz S, Tubbe I, Galle PR, et al. Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27[J]. J Exp Med, 2006, 203(8): 1875-1881. PMID: 16880260. PMCID: PMC2118378. DOI: 10.1084/jem.20060471.
18 Tessema B, Lippmann N, Willenberg A, et al. The diagnostic performance of interleukin-6 and C-reactive protein for early identification of neonatal sepsis[J]. Diagnostics (Basel), 2020, 10(11): 978. PMID: 33233806. PMCID: PMC7699903. DOI: 10.3390/diagnostics10110978.
19 Wong HR, Cvijanovich NZ, Hall M, et al. Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill children[J]. Crit Care, 2012, 16(5): R213. PMID: 23107287. PMCID: PMC3682317. DOI: 10.1186/cc11847.